com,n_com,dgr_int,PY,TI,AU,UT,seed_com
1,18,0.40963785107911405,2018,TARGETING AUTOPHAGY IN THE TUMOR MICROENVIRONMENT: NEW CHALLENGES AND OPPORTUNITIES FOR REGULATING TUMOR IMMUNITY,JANJI B;BERCHEM G;CHOUAIB S,2-S2.0-85046095670,TRUE
1,18,0.29295843708698666,2016,HIJACKER OF THE ANTITUMOR IMMUNE RESPONSE: AUTOPHAGY IS SHOWING ITS WORST FACET,VIRY E;NOMAN MZ;ARAKELIAN T;LEQUEUX A;CHOUAIB S;BERCHEM G;MOUSSAY E;PAGGETTI J;JANJI B,2-S2.0-85006341183,TRUE
1,18,0.24130883042527648,2018,"DRIVING CYTOTOXIC NATURAL KILLER CELLS INTO MELANOMA: IF CCL5 PLAYS THE MUSIC, AUTOPHAGY CALLS THE SHOTS",XIAO M;NOMAN MZ;MENARD L;CHEVIGNE A;SZPAKOWSKA M;BOSSELER M;OLLERT M;BERCHEM G;JANJI B,2-S2.0-85054774893,TRUE
1,18,0.21119298041781853,2016,THE MULTIFACETED ROLE OF AUTOPHAGY IN TUMOR EVASION FROM IMMUNE SURVEILLANCE,JANJI B;VIRY E;MOUSSAY E;PAGGETTI J;ARAKELIAN T;MGRDITCHIAN T;MESSAI Y;NOMAN MZ;VAN MOER K;HASMIM M;MAMI-CHOUAIB F;BERCHEM G;CHOUAIB S,2-S2.0-84975501608,TRUE
1,18,0.19269077859633665,2021,TARGETING HIF-1 ALPHA TRANSCRIPTIONAL ACTIVITY DRIVES CYTOTOXIC IMMUNE EFFECTOR CELLS INTO MELANOMA AND IMPROVES COMBINATION IMMUNOTHERAPY,LEQUEUX A;NOMAN MZ;XIAO M;VAN MOER K;HASMIM M;BENOIT A;BOSSELER M;VIRY E;ARAKELIAN T;BERCHEM G;CHOUAIB S;JANJI B,2-S2.0-85108269122,TRUE
2,16,0.29265294296768396,2020,FORMATE INDUCES A METABOLIC SWITCH IN NUCLEOTIDE AND ENERGY METABOLISM,OIZEL K;TAIT-MULDER J;FERNANDEZ-DE-COSSIO-DIAZ J;PIETZKE M;BRUNTON H;LILLA S;DHAYADE S;ATHINEOS D;BLANCO GR;SUMPTON D;MACKAY GM;BLYTH K;ZANIVAN SR;MEISER J;VAZQUEZ A,2-S2.0-85084228167,TRUE
2,16,0.16238140969675804,2018,INCREASED FORMATE OVERFLOW IS A HALLMARK OF OXIDATIVE CANCER,MEISER J;SCHUSTER A;PIETZKE M;VOORDE JV;ATHINEOS D;OIZEL K;BURGOS-BARRAGAN G;WIT N;DHAYADE S;MORTON JP;DORNIER E;SUMPTON D;MACKAY GM;BLYTH K;PATEL KJ;NICLOU SP;VAZQUEZ A,2-S2.0-85045238581,TRUE
2,16,0.15688646686870833,2018,INHIBITION OF THE MID1 PROTEIN COMPLEX: A NOVEL APPROACH TARGETING APP PROTEIN SYNTHESIS,MATTHES F;HETTICH MM;SCHILLING J;FLORES-DOMINGUEZ D;BLANK N;WIGLENDA T;BUNTRU A;WOLF H;WEBER S;VORBERG I;DAGANE A;DITTMAR G;WANKER E;EHNINGER D;KRAUSS S,2-S2.0-85058029169,TRUE
2,16,0.1434601130251727,2019,DEREGULATED SPLICING IS A MAJOR MECHANISM OF RNA-INDUCED TOXICITY IN HUNTINGTON'S DISEASE,SCHILLING J;BROEMER M;ATANASSOV I;DUERNBERGER Y;VORBERG I;DIETERICH C;DAGANE A;DITTMAR G;WANKER E;VAN ROON-MOM W;WINTER J;KRAUß S,2-S2.0-85061539453,TRUE
2,16,0.1408586149359564,2019,UNIQUE PROPERTIES OF PTEN-L CONTRIBUTE TO NEUROPROTECTION IN RESPONSE TO ISCHEMIC-LIKE STRESS,JOCHNER MCE;AN J;LÄTTIG-TÜNNEMANN G;KIRCHNER M;DAGANE A;DITTMAR G;DIRNAGL U;EICKHOLT BJ;HARMS C,2-S2.0-85062304316,TRUE
3,13,0.18633560376981,2021,PROTOCOL FOR DERIVATION OF ORGANOIDS AND PATIENT-DERIVED ORTHOTOPIC XENOGRAFTS FROM GLIOMA PATIENT TUMORS,OUDIN A;BAUS V;BARTHELEMY V;FABIAN C;KLEIN E;DIETERLE M;WANTZ M;HAU A-C;DORDING C;BERNARD A;MICHELUCCI A;YABO YA;KANLI G;KEUNEN O;BJERKVIG R;NICLOU SP;GOLEBIEWSKA A,2-S2.0-85105598446,TRUE
3,13,0.16074102386726868,2017,"ALTERED METABOLIC LANDSCAPE IN IDH-MUTANT GLIOMAS AFFECTS PHOSPHOLIPID, ENERGY, AND OXIDATIVE STRESS PATHWAYS",FACK F;TARDITO S;HOCHART G;OUDIN A;ZHENG L;FRITAH S;GOLEBIEWSKA A;NAZAROV PV;BERNARD A;HAU A-C;KEUNEN O;LEENDERS W;LUND-JOHANSEN M;STAUBER J;GOTTLIEB E;BJERKVIG R;NICLOU SP,2-S2.0-85035775583,TRUE
3,13,0.13502981486852456,2016,MOLECULAR CROSSTALK BETWEEN TUMOUR AND BRAIN PARENCHYMA INSTRUCTS HISTOPATHOLOGICAL FEATURES IN GLIOBLASTOMA,BOUGNAUD S;GOLEBIEWSKA A;OUDIN A;KEUNEN O;HARTER PN;MÄDER L;AZUAJE F;FRITAH S;STIEBER D;KAOMA T;VALLAR L;BRONS NHC;DAUBON T;MILETIC H;SUNDSTRØM T;HEROLD-MENDE C;MITTELBRONN M;BJERKVIG R;NICLOU SP,2-S2.0-84973582201,TRUE
3,13,0.10147283410828618,2021,IMPACT OF CHROMATIN DYNAMICS AND DNA REPAIR ON GENOMIC STABILITY AND TREATMENT RESISTANCE IN PEDIATRIC HIGH‐GRADE GLIOMAS,PINTO L;BAIDARJAD H;ENTZ‐WERLÉ N;VAN DYCK E,2-S2.0-85119077273,TRUE
3,13,0.09353391706332884,2016,TARGETED PROTEOMICS TO ASSESS THE RESPONSE TO ANTI-ANGIOGENIC TREATMENT IN HUMAN GLIOBLASTOMA (GBM),DEMEURE K;FACK F;DURIEZ E;TIEMANN K;BERNARD A;GOLEBIEWSKA A;BOUGNAUD S;BJERKVIG R;DOMON B;NICLOU SP,2-S2.0-84957895381,TRUE
4,11,0.25488688313659896,2018,EGFR HETEROGENEITY AND IMPLICATIONS FOR THERAPEUTIC INTERVENTION IN GLIOBLASTOMA,ESKILSSON E;RØSLAND GV;SOLECKI G;WANG Q;HARTER PN;GRAZIANI G;VERHAAK RGW;WINKLER F;BJERKVIG R;MILETIC H,2-S2.0-85047747064,TRUE
4,11,0.19818708220013023,2016,EGFRVIII MUTATIONS CAN EMERGE AS LATE AND HETEROGENOUS EVENTS IN GLIOBLASTOMA DEVELOPMENT AND PROMOTE ANGIOGENESIS THROUGH SRC ACTIVATION,ESKILSSON E;ROSLAND GV;TALASILA KM;KNAPPSKOG S;KEUNEN O;SOTTORIVA A;FOERSTER S;SOLECKI G;TAXT T;JIRIK R;FRITAH S;HARTER PN;VÄLK K;AL HOSSAIN J;JOSEPH JV;JAHEDI R;SAED HS;PICCIRILLO SG;SPITERI I;EUSKIRCHEN P;GRAZIANI G;DAUBON T;LUND-JOHANSEN M;ENGER PØ;WINKLER F;RITTER CA;NICLOU SP;WATTS C;BJERKVIG R;MILETIC H,2-S2.0-85006870204,TRUE
4,11,0.1610128097665037,2019,LONG-TERM TREATMENT WITH VALGANCICLOVIR IMPROVES LENTIVIRAL SUICIDE GENE THERAPY OF GLIOBLASTOMA,HOSSAIN JA;LATIF MA;YSTAAS LAR;NINZIMA S;RIECKEN K;MULLER A;AZUAJE F;JOSEPH JV;TALASILA KM;GHIMIRE J;FEHSE B;BJERKVIG R;MILETIC H,2-S2.0-85071157677,TRUE
4,11,0.13447000501596007,2018,LACK OF FUNCTIONAL NORMALISATION OF TUMOUR VESSELS FOLLOWING ANTI-ANGIOGENIC THERAPY IN GLIOBLASTOMA,OBAD N;ESPEDAL H;JIRIK R;SAKARIASSEN PO;BREKKE RYGH C;LUND-JOHANSEN M;TAXT T;NICLOU SP;BJERKVIG R;KEUNEN O,2-S2.0-85045044092,TRUE
4,11,0.12966912000455993,2017,THE ANGIOGENIC SWITCH LEADS TO A METABOLIC SHIFT IN HUMAN GLIOBLASTOMA,TALASILA KM;RØSLAND GV;HAGLAND HR;ESKILSSON E;FLØNES IH;FRITAH S;AZUAJE F;ATAI N;HARTER PN;MITTELBRONN M;ANDERSEN M;JOSEPH JV;AL HOSSAIN J;VALLAR L;VAN NOORDEN CJF;NICLOU SP;THORSEN F;TRONSTAD KJ;TZOULIS C;BJERKVIG R;MILETIC H,2-S2.0-85019724359,TRUE
5,10,0.0798888888888889,2017,INSIGHTS INTO LIGAND STIMULATION EFFECTS ON GASTRO-INTESTINAL STROMAL TUMORS SIGNALLING,BAHLAWANE C;SCHMITZ M;LETELLIER E;ARUMUGAM K;NICOT N;NAZAROV PV;HAAN S,2-S2.0-84994229112,TRUE
5,10,0.07061855670103093,2016,DATA ON QUANTIFICATION OF SIGNALING PATHWAYS ACTIVATED BY KIT AND PDGFRA MUTANTS,BAHLAWANE C;SCHMITZ M;LETELLIER E;ARUMUGAM K;NICOT N;NAZAROV PV;HAAN S,2-S2.0-85020932629,TRUE
5,10,0.06635971223021583,2021,PRISMA AND BIOID DISCLOSE A MOTIFS-BASED INTERACTOME OF THE INTRINSICALLY DISORDERED TRANSCRIPTION FACTOR C/EBPΑ,RAMBERGER E;SAPOZHNIKOVA V;KOWENZ-LEUTZ E;ZIMMERMANN K;NICOT N;NAZAROV PV;PEREZ-HERNANDEZ D;REIMER U;MERTINS P;DITTMAR G;LEUTZ A,2-S2.0-85108084516,TRUE
5,10,0.050359712230215826,2019,PRISMA: PROTEIN INTERACTION SCREEN ON PEPTIDE MATRIX REVEALS INTERACTION FOOTPRINTS AND MODIFICATIONS- DEPENDENT INTERACTOME OF INTRINSICALLY DISORDERED C/EBPΒ,DITTMAR G;HERNANDEZ DP;KOWENZ-LEUTZ E;KIRCHNER M;KAHLERT G;WESOLOWSKI R;BAUM K;KNOBLICH M;HOFSTÄTTER M;MULLER A;WOLF J;REIMER U;LEUTZ A,2-S2.0-85066253803,TRUE
5,10,0.0483963344788087,2020,HYPOXIA-INDUCED ADAPTATIONS OF MIRNOMES AND PROTEOMES IN MELANOMA CELLS AND THEIR SECRETED EXTRACELLULAR VESICLES,WALBRECQ G;LECHA O;GAIGNEAUX A;FOUGERAS MR;PHILIPPIDOU D;MARGUE C;NOMIGNI MT;BERNARDIN F;DITTMAR G;BEHRMANN I;KREIS S,2-S2.0-85082494633,TRUE
6,9,0.09295252846182694,2020,ACTIN REMODELING AND VESICULAR TRAFFICKING AT THE TUMOR CELL SIDE OF THE IMMUNOLOGICAL SYNAPSE DIRECT EVASION FROM CYTOTOXIC LYMPHOCYTES,BIOLATO AM;FILALI L;WURZER H;HOFFMANN C;GARGIULO E;VALITUTTI S;THOMAS C,2-S2.0-85090577630,TRUE
6,9,0.08628096392181259,2021,THE MULTIPLE ROLES OF ACTIN-BINDING PROTEINS AT INVADOPODIA,MGRDITCHIAN T;SAKALAUSKAITE G;MÜLLER T;HOFFMANN C;THOMAS C,2-S2.0-85104061708,TRUE
6,9,0.08087661500006701,2018,ACTIN CYTOSKELETON REMODELING DRIVES BREAST CANCER CELL ESCAPE FROM NATURAL KILLER-MEDIATED CYTOTOXICITY,ABSI AA;WURZER H;GUERIN C;HOFFMANN C;MOREAU F;MAO X;BROWN-CLAY J;PETROLLI R;CASELLAS CP;DIETERLE M;THIERY J-P;CHOUAIB S;BERCHEM G;JANJI B;THOMAS C,2-S2.0-85054100455,TRUE
6,9,0.061040772503276094,2020,ESCAPE OF TUMOR CELLS FROM THE NK CELL CYTOTOXIC ACTIVITY,CANTONI C;WURZER H;THOMAS C;VITALE M,2-S2.0-85090981878,TRUE
6,9,0.038709654540738575,2021,INTRINSIC RESISTANCE OF CHRONIC LYMPHOCYTIC LEUKEMIA CELLS TO NK CELL-MEDIATED LYSIS CAN BE OVERCOME IN VITRO BY PHARMACOLOGICAL INHIBITION OF CDC42-INDUCED ACTIN CYTOSKELETON REMODELING,WURZER H;FILALI L;HOFFMANN C;KRECKE M;BIOLATO AM;MASTIO J;DE WILDE S;FRANÇOIS JH;LARGEOT A;BERCHEM G;PAGGETTI J;MOUSSAY E;THOMAS C,2-S2.0-85107458366,TRUE
7,9,0.2478119918855828,2016,PARALLEL REACTION MONITORING USING QUADRUPOLE-ORBITRAP MASS SPECTROMETER: PRINCIPLE AND APPLICATIONS,BOURMAUD A;GALLIEN S;DOMON B,2-S2.0-84983293026,TRUE
7,9,0.24580964459137786,2016,COMPLEXITY REDUCTION OF CLINICAL SAMPLES FOR ROUTINE MASS SPECTROMETRIC ANALYSIS,MESMIN C;VAN OOSTRUM J;DOMON B,2-S2.0-84958068652,TRUE
7,9,0.23051952062417685,2016,DEVELOPMENT OF A SEQUENTIAL WORKFLOW BASED ON LC-PRM FOR THE VERIFICATION OF ENDOMETRIAL CANCER PROTEIN BIOMARKERS IN UTERINE ASPIRATE SAMPLES,MARTINEZ-GARCIA E;LESUR A;DEVIS L;CAMPOS AR;CABRERA S;VAN OOSTRUM J;MATIAS-GUIU X;GIL-MORENO A;REVENTOS J;COLAS E;DOMON B,2-S2.0-84982245280,TRUE
7,9,0.14509812199027589,2017,LARGE-SCALE SRM SCREEN OF UROTHELIAL BLADDER CANCER CANDIDATE BIOMARKERS IN URINE,DURIEZ E;MASSELON CD;MESMIN C;COURT M;DEMEURE K;ALLORY Y;MALATS N;MATONDO M;RADVANYI F;GARIN J;DOMON B,2-S2.0-85016958917,TRUE
7,9,0.13806274457087975,2018,ADVANCES IN ENDOMETRIAL CANCER PROTEIN BIOMARKERS FOR USE IN THE CLINIC,MARTINEZ-GARCIA E;LOPEZ-GIL C;CAMPOY I;VALLVE J;COLL E;CABRERA S;RAMON Y CAJAL S;MATIAS-GUIU X;VAN OOSTRUM J;REVENTOS J;GIL-MORENO A;COLAS E,2-S2.0-85039855721,TRUE
8,7,0.2528547956164002,2019,"H-1 PARVOVIRUS AS A CANCER-KILLING AGENT: PAST, PRESENT, AND FUTURE",BRETSCHER C;MARCHINI A,2-S2.0-85068492771,TRUE
8,7,0.16737139049607075,2021,ONCOLYTIC H-1 PARVOVIRUS BINDS TO SIALIC ACID ON LAMININS FOR CELL ATTACHMENT AND ENTRY,KULKARNI A;FERREIRA T;BRETSCHER C;GREWENIG A;EL-ANDALOUSSI N;BONIFATI S;MARTTILA T;PALISSOT V;HOSSAIN JA;AZUAJE F;MILETIC H;YSTAAS LAR;GOLEBIEWSKA A;NICLOU SP;ROETH R;NIESLER B;WEISS A;BRINO L;MARCHINI A,2-S2.0-85108334249,TRUE
8,7,0.1673663326578576,2021,PARVOVIRUS-BASED COMBINATORIAL IMMUNOTHERAPY: A REINFORCED THERAPEUTIC STRATEGY AGAINST POOR-PROGNOSIS SOLID CANCERS,ANGELOVA A;FERREIRA T;BRETSCHER C;ROMMELAERE J;MARCHINI A,2-S2.0-85099949760,TRUE
8,7,0.1463729957516907,2021,"VIROTHERAPY IN GERMANY—RECENT ACTIVITIES IN VIRUS ENGINEERING, PRECLINICAL DEVELOPMENT, AND CLINICAL STUDIES",NETTELBECK DM;LEBER MF;ALTOMONTE J;ANGELOVA A;BEIL J;BERCHTOLD S;DELIC M;EBERLE J;EHRHARDT A;ENGELAND CE;FECHNER H;GELETNEKY K;GOEPFERT K;HOLM PS;KOCHANEK S;KREPPEL F;KRUTZKE L;KÜHNEL F;LANG KS;MARCHINI A;MOEHLER M;MÜHLEBACH MD;NAUMANN U;NAWROTH R;NÜESCH J;ROMMELAERE J;LAUER UM;UNGERECHTS G,2-S2.0-85111430945,TRUE
8,7,0.13907486219624948,2020,ONCOLYTIC H-1 PARVOVIRUS ENTERS CANCER CELLS THROUGH CLATHRIN-MEDIATED ENDOCYTOSIS,FERREIRA T;KULKARNI A;BRETSCHER C;RICHTER K;EHRLICH M;MARCHINI A,2-S2.0-85093521930,TRUE
9,7,0.3782340723302463,2018,CD47 IS A DIRECT TARGET OF SNAI1 AND ZEB1 AND ITS BLOCKADE ACTIVATES THE PHAGOCYTOSIS OF BREAST CANCER CELLS UNDERGOING EMT,NOMAN MZ;VAN MOER K;MARANI V;GEMMILL RM;TRANCHEVENT L-C;AZUAJE F;MULLER A;CHOUAIB S;THIERY JP;BERCHEM G;JANJI B,2-S2.0-85042069041,TRUE
9,7,0.3169601734722484,2021,EPITHELIAL TO MESENCHYMAL TRANSITION REGULATES SURFACE PD-L1 VIA CMTM6 AND CMTM7 INDUCTION IN BREAST CANCER,XIAO M;HASMIM M;LEQUEUX A;VAN MOER K;TAN TZ;GILLES C;HOLLIER BG;THIERY JP;BERCHEM G;JANJI B;NOMAN MZ,2-S2.0-85102117735,TRUE
9,7,0.3016035268348136,2017,THE IMMUNE CHECKPOINT LIGAND PD-L1 IS UPREGULATED IN EMT-ACTIVATED HUMAN BREAST CANCER CELLS BY A MECHANISM INVOLVING ZEB-1 AND MIR-200,NOMAN MZ;JANJI B;ABDOU A;HASMIM M;TERRY S;TAN TZ;MAMI-CHOUAIB F;THIERY JP;CHOUAIB S,2-S2.0-85021038369,TRUE
9,7,0.28586433609985984,2019,IMPACT OF HYPOXIC TUMOR MICROENVIRONMENT AND TUMOR CELL PLASTICITY ON THE EXPRESSION OF IMMUNE CHECKPOINTS,LEQUEUX A;NOMAN MZ;XIAO M;SAUVAGE D;VAN MOER K;VIRY E;BOCCI I;HASMIM M;BOSSELER M;BERCHEM G;JANJI B,2-S2.0-85066249277,TRUE
9,7,0.2188344167676778,2019,IMPROVING CANCER IMMUNOTHERAPY BY TARGETING THE HYPOXIC TUMOR MICROENVIRONMENT: NEW OPPORTUNITIES AND CHALLENGES,NOMAN MZ;HASMIM M;LEQUEUX A;XIAO M;DUHEM C;CHOUAIB S;BERCHEM G;JANJI B,2-S2.0-85077470251,TRUE
10,7,0.07351114061518507,2019,HEMATOLOGICAL MALIGNANCY-DERIVED SMALL EXTRACELLULAR VESICLES AND TUMOR MICROENVIRONMENT: THE ART OF TURNING FOES INTO FRIENDS,GARGIULO E;PAGGETTI J;MOUSSAY E,2-S2.0-85083503859,TRUE
10,7,0.05976208580174189,2017,TUMOR-DERIVED EXOSOMES MODULATE PD-L1 EXPRESSION IN MONOCYTES,HADERK F;SCHULZ R;ISKAR M;CID LL;WORST T;WILLMUND KV;SCHULZ A;WARNKEN U;SEILER J;BENNER A;NESSLING M;ZENZ T;GÖBEL M;DÜRIG J;DIEDERICHS S;PAGGETTI J;MOUSSAY E;STILGENBAUER S;ZAPATKA M;LICHTER P;SEIFFERT M,2-S2.0-85032353718,TRUE
10,7,0.04286950186686094,2020,DIAGNOSTIC AND THERAPEUTIC POTENTIAL OF EXTRACELLULAR VESICLES IN B-CELL MALIGNANCIES,GARGIULO E;MORANDE PE;LARGEOT A;MOUSSAY E;PAGGETTI J,2-S2.0-85092489042,TRUE
10,7,0.04285714285714286,2020,PITUITARY TUMOR TRANSFORMING GENE 1 ORCHESTRATES GENE REGULATORY VARIATION IN MOUSE VENTRAL MIDBRAIN DURING AGING,GUI Y;THOMAS MH;GARCIA P;KAROUT M;HALDER R;MICHELUCCI A;KOLLMUS H;ZHOU C;MELMED S;SCHUGHART K;BALLING R;MITTELBRONN M;NADEAU JH;WILLIAMS RW;SAUTER T;BUTTINI M;SINKKONEN L,2-S2.0-85092157692,TRUE
10,7,0.03968253968253968,2020,HIF-1Α IS INVOLVED IN BLOOD–BRAIN BARRIER DYSFUNCTION AND PARACELLULAR MIGRATION OF BACTERIA IN PNEUMOCOCCAL MENINGITIS,DEVRAJ G;GUÉRIT S;SEELE J;SPITZER D;MACAS J;KHEL MI;HEIDEMANN R;BRACZYNSKI AK;BALLHORN W;GÜNTHER S;OGUNSHOLA OO;MITTELBRONN M;KÖDEL U;MONORANU CM;PLATE KH;HAMMERSCHMIDT S;NAU R;DEVRAJ K;KEMPF VAJ,2-S2.0-85086327514,TRUE
11,6,0.24260825361817193,2021,MICROGLIA IN HEALTH AND DISEASE: THE STRENGTH TO BE DIVERSE AND REACTIVE,URIARTE HUARTE O;RICHART L;MITTELBRONN M;MICHELUCCI A,2-S2.0-85104174162,FALSE
11,6,0.22580411967134892,2021,SINGLE-CELL TRANSCRIPTOMICS AND IN SITU MORPHOLOGICAL ANALYSES REVEAL MICROGLIA HETEROGENEITY ACROSS THE NIGROSTRIATAL PATHWAY,URIARTE HUARTE O;KYRIAKIS D;HEURTAUX T;PIRES-AFONSO Y;GRZYB K;HALDER R;BUTTINI M;SKUPIN A;MITTELBRONN M;MICHELUCCI A,2-S2.0-85104006825,FALSE
11,6,0.11962078793263323,2020,REVEALING AND HARNESSING TUMOUR-ASSOCIATED MICROGLIA/MACROPHAGE HETEROGENEITY IN GLIOBLASTOMA,PIRES-AFONSO Y;NICLOU SP;MICHELUCCI A,2-S2.0-85078243244,FALSE
11,6,0.0910205043499588,2018,SINGLE-CELL TRANSCRIPTOMICS REVEALS DISTINCT INFLAMMATION-INDUCED MICROGLIA SIGNATURES,SOUSA C;GOLEBIEWSKA A;POOVATHINGAL SK;KAOMA T;PIRES-AFONSO Y;MARTINA S;COOWAR D;AZUAJE F;SKUPIN A;BALLING R;BIBER K;NICLOU SP;MICHELUCCI A,2-S2.0-85053306989,FALSE
11,6,0.08106408106833236,2017,CELLULAR AND MOLECULAR CHARACTERIZATION OF MICROGLIA: A UNIQUE IMMUNE CELL POPULATION,SOUSA C;BIBER K;MICHELUCCI A,2-S2.0-85017151621,FALSE
12,5,0.17859457615555177,2018,DNA METHYLATION-BASED CLASSIFICATION OF CENTRAL NERVOUS SYSTEM TUMOURS,CAPPER D;JONES DTW;SILL M;HOVESTADT V;SCHRIMPF D;STURM D;KOELSCHE C;SAHM F;CHAVEZ L;REUSS DE;KRATZ A;WEFERS AK;HUANG K;PAJTLER KW;SCHWEIZER L;STICHEL D;OLAR A;ENGEL NW;LINDENBERG K;HARTER PN;BRACZYNSKI AK;PLATE KH;DOHMEN H;GARVALOV BK;CORAS R;HÖLSKEN A;HEWER E;BEWERUNGE-HUDLER M;SCHICK M;FISCHER R;BESCHORNER R;SCHITTENHELM J;STASZEWSKI O;WANI K;VARLET P;PAGES M;TEMMING P;LOHMANN D;SELT F;WITT H;MILDE T;WITT O;ARONICA E;GIANGASPERO F;RUSHING E;SCHEURLEN W;GEISENBERGER C;RODRIGUEZ FJ;BECKER A;PREUSSER M;HABERLER C;BJERKVIG R;CRYAN J;FARRELL M;DECKERT M;HENCH J;FRANK S;SERRANO J;KANNAN K;TSIRIGOS A;BRÜCK W;HOFER S;BREHMER S;SEIZ-ROSENHAGEN M;HÄNGGI D;HANS V;ROZSNOKI S;HANSFORD JR;KOHLHOF P;KRISTENSEN BW;LECHNER M;LOPES B;MAWRIN C;KETTER R;KULOZIK A;KHATIB Z;HEPPNER F;KOCH A;JOUVET A;KEOHANE C;MÜHLEISEN H;MUELLER W;POHL U;PRINZ M;BENNER A;ZAPATKA M;GOTTARDO NG;DRIEVER PH;KRAMM CM;MÜLLER HL;RUTKOWSKI S;VON HOFF K;FRÜHWALD MC;GNEKOW A;FLEISCHHACK G;TIPPELT S;CALAMINUS G;MONORANU C-M;PERRY A;JONES C;JACQUES TS;RADLWIMMER B;GESSI M;PIETSCH T;SCHRAMM J;SCHACKERT G;WESTPHAL M;REIFENBERGER G;WESSELING P;WELLER M;COLLINS VP;BLÜMCKE I;BENDSZUS M;DEBUS J;HUANG A;JABADO N;NORTHCOTT PA;PAULUS W;GAJJAR A;ROBINSON GW;TAYLOR MD;JAUNMUKTANE Z;RYZHOVA M;PLATTEN M;UNTERBERG A;WICK W;KARAJANNIS MA;MITTELBRONN M;ACKER T;HARTMANN C;ALDAPE K;SCHÜLLER U;BUSLEI R;LICHTER P;KOOL M;HEROLD-MENDE C;ELLISON DW;HASSELBLATT M;SNUDERL M;BRANDNER S;KORSHUNOV A;VON DEIMLING A;PFISTER SM,2-S2.0-85044262739,FALSE
12,5,0.16361788617886178,2021,SARCOMA CLASSIFICATION BY DNA METHYLATION PROFILING,KOELSCHE C;SCHRIMPF D;STICHEL D;SILL M;SAHM F;REUSS DE;BLATTNER M;WORST B;HEILIG CE;BECK K;HORAK P;KREUTZFELDT S;PAFF E;STARK S;JOHANN P;SELT F;ECKER J;STURM D;PAJTLER KW;REINHARDT A;WEFERS AK;SIEVERS P;EBRAHIMI A;SUWALA A;FERNÁNDEZ-KLETT F;CASALINI B;KORSHUNOV A;HOVESTADT V;KOMMOSS FKF;KRIEGSMANN M;SCHICK M;BEWERUNGE-HUDLER M;MILDE T;WITT O;KULOZIK AE;KOOL M;ROMERO-PÉREZ L;GRÜNEWALD TGP;KIRCHNER T;WICK W;PLATTEN M;UNTERBERG A;UHL M;ABDOLLAHI A;DEBUS J;LEHNER B;THOMAS C;HASSELBLATT M;PAULUS W;HARTMANN C;STASZEWSKI O;PRINZ M;HENCH J;FRANK S;VERSLEIJEN-JONKERS YMH;WEIDEMA ME;MENTZEL T;GRIEWANK K;DE ÁLAVA E;MARTÍN JD;GASTEARENA MAI;CHANG KT-E;LOW SYY;CUEVAS-BOURDIER A;MITTELBRONN M;MYNAREK M;RUTKOWSKI S;SCHÜLLER U;MAUTNER VF;SCHITTENHELM J;SERRANO J;SNUDERL M;BÜTTNER R;KLINGEBIEL T;BUSLEI R;GESSLER M;WESSELING P;DINJENS WNM;BRANDNER S;JAUNMUKTANE Z;LYSKJÆR I;SCHIRMACHER P;STENZINGER A;BRORS B;GLIMM H;HEINING C;TIRADO OM;SÁINZ-JASPEADO M;MORA J;ALONSO J;DEL MURO XG;MORAN S;ESTELLER M;BENHAMIDA JK;LADANYI M;WARDELMANN E;ANTONESCU C;FLANAGAN A;DIRKSEN U;HOHENBERGER P;BAUMHOER D;HARTMANN W;VOKUHL C;FLUCKE U;PETERSEN I;MECHTERSHEIMER G;CAPPER D;JONES DTW;FRÖHLING S;PFISTER SM;VON DEIMLING A,2-S2.0-85099975144,FALSE
12,5,0.11844030416136678,2020,TARGETABLE ERBB2 MUTATIONS IDENTIFIED IN NEUROFIBROMA/SCHWANNOMA HYBRID NERVE SHEATH TUMORS,RONELLENFITSCH MW;HARTER PN;KIRCHNER M;HEINING C;HUTTER B;GIELDON L;SCHITTENHELM J;SCHUHMANN MU;TATAGIBA M;MARQUARDT G;WAGNER M;ENDRIS V;BRANDTS CH;MAUTNER V-F;SCHRÖCK E;WEICHERT W;BRORS B;VON DEIMLING A;MITTELBRONN M;STEINBACH JP;REUSS DE;GLIMM H;STENZINGER A;FRÖHLING S,2-S2.0-85084220594,FALSE
12,5,0.07370079996808107,2019,LONGITUDINAL MOLECULAR TRAJECTORIES OF DIFFUSE GLIOMA IN ADULTS,BARTHEL FP;JOHNSON KC;VARN FS;MOSKALIK AD;TANNER G;KOCAKAVUK E;ANDERSON KJ;ABIOLA O;ALDAPE K;ALFARO KD;ALPAR D;AMIN SB;ASHLEY DM;BANDOPADHAYAY P;BARNHOLTZ-SLOAN JS;BEROUKHIM R;BOCK C;BRASTIANOS PK;BRAT DJ;BRODBELT AR;BRUNS AF;BULSARA KR;CHAKRABARTY A;CHAKRAVARTI A;CHUANG JH;CLAUS EB;COCHRAN EJ;CONNELLY J;COSTELLO JF;FINOCCHIARO G;FLETCHER MN;FRENCH PJ;GAN HK;GILBERT MR;GOULD PV;GRIMMER MR;IAVARONE A;ISMAIL A;JENKINSON MD;KHASRAW M;KIM H;KOUWENHOVEN MCM;LAVIOLETTE PS;LI M;LICHTER P;LIGON KL;LOWMAN AK;MALTA TM;MAZOR T;MCDONALD KL;MOLINARO AM;NAM D-H;NAYYAR N;NG HK;NGAN CY;NICLOU SP;NIERS JM;NOUSHMEHR H;NOORBAKHSH J;ORMOND DR;PARK C-K;POISSON LM;RABADAN R;RADLWIMMER B;RAO G;REIFENBERGER G;SA JK;SCHUSTER M;SHAW BL;SHORT SC;SILLEVIS SMITT PA;SLOAN AE;SMITS M;SUZUKI H;TABATABAI G;VAN MEIR EG;WATTS C;WELLER M;WESSELING P;WESTERMAN BA;WIDHALM G;WOEHRER A;YUNG WKA;ZADEH G;HUSE JT;DE GROOT JF;STEAD LF;VERHAAK RGW;THE GLIOMA LONGITUDINAL ANALYSIS (GLASS) CONSORTIUM,2-S2.0-85075234677,FALSE
12,5,0.05082032813125251,2021,CONSERVATION OF COPY NUMBER PROFILES DURING ENGRAFTMENT AND PASSAGING OF PATIENT-DERIVED CANCER XENOGRAFTS,WOO XY;GIORDANO J;SRIVASTAVA A;ZHAO Z-M;LLOYD MW;DE BRUIJN R;SUH Y-S;PATIDAR R;CHEN L;SCHERER S;BAILEY MH;YANG C-H;CORTES-SANCHEZ E;XI Y;WANG J;WICKRAMASINGHE J;KOSSENKOV AV;REBECCA VW;SUN H;MASHL RJ;DAVIES SR;JEON R;FRECH C;RANDJELOVIC J;ROSAINS J;GALIMI F;BERTOTTI A;LAFFERTY A;O'FARRELL AC;MODAVE E;LAMBRECHTS D;TER BRUGGE P;SERRA V;MARANGONI E;EL BOTTY R;KIM H;KIM J-I;YANG H-K;LEE C;DEAN DA;II;DAVIS-DUSENBERY B;EVRARD YA;DOROSHOW JH;WELM AL;WELM BE;LEWIS MT;FANG B;ROTH JA;MERIC-BERNSTAM F;HERLYN M;DAVIES MA;DING L;LI S;GOVINDAN R;ISELLA C;MOSCOW JA;TRUSOLINO L;BYRNE AT;JONKERS J;BULT CJ;MEDICO E;CHUANG JH;BAILEY MH;REBECCA VW;DAVIES MA;ROBINSON PN;SANDERSON BJ;NEUHAUSER SB;DOBROLECKI LE;ZHENG X;MAJIDI M;ZHANG R;ZHANG X;AKCAKANAT A;EVANS KW;YAP TA;LI D;YUCAN E;LANIER CD;SARIDOGAN T;KIRBY BP;HA MJ;CHEN H;KOPETZ S;MENTER DG;ZHANG J;WESTIN SN;KIM MP;DAI B;GIBBONS DL;TAPIA C;JENSEN VB;BONING G;MINNA JD;PARK H;TIMMONS BC;GIRARD L;FINGERMAN D;LIU Q;SOMASUNDARAM R;XIAO M;YENNU-NANDA VG;TETZLAFF MT;XU X;NATHANSON KL;CAO S;CHEN F;DIPERSIO JF;LIM KH;MA CX;RODRIGUEZ FM;VAN TINE BA;WANG-GILLAM A;WENDL MC;WU Y;WYCZALKOWSKI MA;YAO L;JAYASINGHE R;AFT RL;FIELDS RC;LUO J;FUH KC;CHIN V;DIGIOVANNA J;GROVER J;KOC S;SEEPO S;WALLACE T;PAN C-X;CHEN MS;JR;CARVAJAL-CARMONA LG;KIRANE AR;CHO M;GANDARA DR;RIESS JW;LE T;DEVERE WHITE RW;TEPPER CG;ZHANG H;COGGINS NB;LOTT P;ESTRADA A;TOAL T;ARANA AM;POLANCO-ECHEVERRY G;ROCHA S;MA A-H;MITSIADES N;KAOCHAR S;O'MALLEY BW;ELLIS MJ;HILSENBECK SG;ITTMANN M;DE BRUIJN R;TER BRUGGE P;CORSO S;FIORI A;GIORDANO S;VAN DE VEN M;PEEPER DS;MILLER I;BERNADÓ C;MORANCHO B;RAMÍREZ L;ARRIBAS J;PALMER HG;PIRIS-GIMENEZ A;SOUCEK L;DAHMANI A;MONTAUDON E;NEMATI F;DANGLES-MARIE V;DECAUDIN D;ROMAN-ROMAN S;ALFÉREZ DG;SPENCE K;CLARKE RB;BENTIRES-ALJ M;CHANG DK;BIANKIN AV;BRUNA A;O'REILLY M;CALDAS C;CASANOVAS O;GONZALEZ-SUAREZ E;MUÑOZ P;VILLANUEVA A;CONTE N;MASON J;THORNE R;MEEHAN TF;PARKINSON H;DUDOVA Z;KŘENEK A;STUCHLÍK D;ELEMENTO O;INGHIRAMI G;GOLEBIEWSKA A;NICLOU SP;WISMAN GBA;DE JONG S;KRALOVA P;SEDLACEK R;CLAEYS E;LEUCCI E;BORSANI M;LANFRANCONE L;PELICCI PG;MÆLANDSMO GM;NORUM JH;VINOLO E;PDXNET CONSORTIUM;EUROPDX CONSORTIUM,2-S2.0-85099251929,FALSE
13,5,0.18275525325461653,2020,PATIENT-DERIVED ORGANOIDS AND ORTHOTOPIC XENOGRAFTS OF PRIMARY AND RECURRENT GLIOMAS REPRESENT RELEVANT PATIENT AVATARS FOR PRECISION ONCOLOGY,GOLEBIEWSKA A;HAU A-C;OUDIN A;STIEBER D;YABO YA;BAUS V;BARTHELEMY V;KLEIN E;BOUGNAUD S;KEUNEN O;WANTZ M;MICHELUCCI A;NEIRINCKX V;MULLER A;KAOMA T;NAZAROV PV;AZUAJE F;DE FALCO A;FLIES B;RICHART L;POOVATHINGAL S;ARNS T;GRZYB K;MOCK A;HEROLD-MENDE C;STEINO A;BROWN D;MAY P;MILETIC H;MALTA TM;NOUSHMEHR H;KWON Y-J;JAHN W;KLINK B;TANNER G;STEAD LF;MITTELBRONN M;SKUPIN A;HERTEL F;BJERKVIG R;NICLOU SP,2-S2.0-85091876218,FALSE
13,5,0.13249854397204425,2020,GLIOBLASTOMA ORGANOIDS: PRE-CLINICAL APPLICATIONS AND CHALLENGES IN THE CONTEXT OF IMMUNOTHERAPY,KLEIN E;HAU A-C;OUDIN A;GOLEBIEWSKA A;NICLOU SP,2-S2.0-85098092986,FALSE
13,5,0.03592814371257485,2019,A DNA REPAIR AND CELL-CYCLE GENE EXPRESSION SIGNATURE IN PRIMARY AND RECURRENT GLIOBLASTOMA: PROGNOSTIC VALUE AND CLINICAL IMPLICATIONS,GOBIN M;NAZAROV PV;WARTA R;TIMMER M;REIFENBERGER G;FELSBERG J;VALLAR L;CHALMERS AJ;HEROLD-MENDE CC;GOLDBRUNNER R;NICLOU SP;VAN DYCK E,2-S2.0-85063003841,FALSE
13,5,0.026280056577086278,2020,INTERFERING WITH LONG NON-CODING RNA MIR22HG PROCESSING INHIBITS GLIOBLASTOMA PROGRESSION THROUGH SUPPRESSION OF WNT/B-CATENIN SIGNALLING,HAN M;WANG S;FRITAH S;WANG X;ZHOU W;YANG N;NI S;HUANG B;CHEN A;LI G;MILETIC H;THORSEN F;BJERKVIG R;LI X;WANG J,2-S2.0-85079250201,FALSE
13,5,0.01775147928994083,2019,DISTRIBUTION AND PROGNOSTIC IMPACT OF MICROGLIA/MACROPHAGE SUBPOPULATIONS IN GLIOMAS,ZEINER PS;PREUSSE C;GOLEBIEWSKA A;ZINKE J;IRIONDO A;MULLER A;KAOMA T;FILIPSKI K;MÜLLER-ESCHNER M;BERNATZ S;BLANK A-E;BAUMGARTEN P;ILINA E;GROTE A;HANSMANN ML;VERHOFF MA;FRANZ K;FEUERHAKE F;STEINBACH JP;WISCHHUSEN J;STENZEL W;NICLOU SP;HARTER PN;MITTELBRONN M,2-S2.0-85067383704,FALSE
14,3,0.07165223798121201,2021,NF-ΚB AND TNF AFFECT THE ASTROCYTIC DIFFERENTIATION FROM NEURAL STEM CELLS,BIRCK C;GINOLHAC A;PAVLOU MAS;MICHELUCCI A;HEUSCHLING P;GRANDBARBE L,2-S2.0-85105148647,FALSE
14,3,0.0666475767771494,2016,TRANSCRIPTOMIC ANALYSES OF PRIMARY ASTROCYTES UNDER TNFΑ TREATMENT,BIRCK C;KONCINA E;HEURTAUX T;GLAAB E;MICHELUCCI A;HEUSCHLING P;GRANDBARBE L,2-S2.0-84947815245,FALSE
14,3,0.03993915902065649,2019,TRANSCRIPTIONAL AND EPIGENETIC MECHANISMS UNDERLYING ASTROCYTE IDENTITY,PAVLOU MAS;GRANDBARBE L;BUCKLEY NJ;NICLOU SP;MICHELUCCI A,2-S2.0-85059701030,FALSE
15,3,0.07472527472527472,2019,THE INVASIVE PROTEOME OF GLIOBLASTOMA REVEALED BY LASER-CAPTURE MICRODISSECTION,DAUBON T;GUYON J;RAYMOND A-A;DARTIGUES B;RUDEWICZ J;EZZOUKHRY Z;DUPUY J-W;HERBERT JMJ;SALTEL F;BJERKVIG R;NIKOLSKI M;BIKFALVI A,2-S2.0-85085518575,FALSE
15,3,0.06940966010733453,2020,IMPROVED RISK STRATIFICATION IN YOUNGER IDH WILD-TYPE GLIOBLASTOMA PATIENTS BY COMBINING A 4-MIRNA SIGNATURE WITH MGMT PROMOTER METHYLATION STATUS,UNGER K;FLEISCHMANN DF;RUF V;FELSBERG J;PIEHLMAIER D;SAMAGA D;HESS J;SURESH MP;MITTELBRONN M;LAUBER K;BUDACH W;SABEL M;RÖDEL C;REIFENBERGER G;HERMS J;TONN J-C;ZITZELSBERGER H;BELKA C;NIYAZI M,2-S2.0-85126587746,FALSE
15,3,0.05182724252491694,2021,CYSTATHIONINE-Γ-LYASE DRIVES ANTIOXIDANT DEFENSE IN CYSTEINE-RESTRICTED IDH1-MUTANT ASTROCYTOMAS,CANO-GALIANO A;OUDIN A;FACK F;ALLEGA M-F;SUMPTON D;MARTINEZ-GARCIA E;DITTMAR G;HAU A-C;DE FALCO A;HEROLD-MENDE C;BJERKVIG R;MEISER J;TARDITO S;NICLOU SP,2-S2.0-85114356655,FALSE
16,2,0.06756756756756757,2021,ACTIVE COMPONENTS FROM CASSIA ABBREVIATA PREVENT HIV-1 ENTRY BY DISTINCT MECHANISMS OF ACTION,ZHENG Y;YANG X-W;SCHOLS D;MORI M;BOTTA B;CHEVIGNÉ A;MULINGE M;STEINMETZ A;SCHMIT J-C;SEGUIN-DEVAUX C,2-S2.0-85105537913,FALSE
16,2,0.06756756756756757,2021,CHEMICAL CONSTITUENTS OF CASSIA ABBREVIATA AND THEIR ANTI-HIV-1 ACTIVITY,YANG X;HE Z;ZHENG Y;WANG N;MULINGE M;SCHMIT J-C;STEINMETZ A;SEGUIN-DEVAUX C,2-S2.0-85105085222,FALSE
17,2,0.09090909090909091,2021,DIFFERENTIATION OF PRIMARY CNS LYMPHOMA AND GLIOBLASTOMA USING RAMAN SPECTROSCOPY AND MACHINE LEARNING ALGORITHMS,KLAMMINGER GG;KLEIN K;MOMBAERTS L;JELKE F;MIRIZZI G;SLIMANI R;HUSCH A;MITTELBRONN M;HERTEL F;BORGMANN FBK,2-S2.0-85129415822,FALSE
17,2,0.09090909090909091,2021,APPLICATION OF RAMAN SPECTROSCOPY FOR DETECTION OF HISTOLOGICALLY DISTINCT AREAS IN FORMALIN-FIXED PARAFFIN-EMBEDDED GLIOBLASTOMA,KLAMMINGER GG;GÉRARDY J-J;JELKE F;MIRIZZI G;SLIMANI R;KLEIN K;HUSCH A;HERTEL F;MITTELBRONN M;KLEINE-BORGMANN FB,2-S2.0-85126574198,FALSE
18,2,0.06474820143884892,2019,MISTLETOE-BASED DRUGS WORK IN SYNERGY WITH RADIO-CHEMOTHERAPY IN THE TREATMENT OF GLIOMA IN VITRO AND IN VIVO IN GLIOBLASTOMA BEARING MICE,SCHÖTTERL S;MIEMIETZ JT;ILINA EI;WIRSIK NM;EHRLICH I;GALL A;HUBER SM;LENTZEN H;MITTELBRONN M;NAUMANN U,2-S2.0-85069043979,FALSE
18,2,0.06474820143884892,2018,ADJUVANT THERAPY USING MISTLETOE CONTAINING DRUGS BOOSTS THE T-CELL-MEDIATED KILLING OF GLIOMA CELLS AND PROLONGS THE SURVIVAL OF GLIOMA BEARING MICE,SCHÖTTERL S;HUBER SM;LENTZEN H;MITTELBRONN M;NAUMANN U,2-S2.0-85053395655,FALSE
